Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Evaluator-Blinded Study to Assess the Safety and Efficacy of NOX1416 in the Treatment of Chronic, Non-Healing, Diabetic Foot Ulcers

NCT06402565 is registered in ClinicalTrials.gov with NOxy Health Products, LLC as lead sponsor.

NCT NCT06402565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06402565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Evaluator-Blinded Study to Assess the Safety and Efficacy of NOX1416 in the Treatment of Chronic, Non-Healing, Diabetic Foot Ulcers
Lead sponsor
NOxy Health Products, LLC
Phase
Phase 1
Overall status
Active, not recruiting
Start date
June 6, 2024
Completion date
June 30, 2026
Enrollment
40 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer